Details of the Drug Reposition

General Information of This Drug (ID: DMTQJE0)

Drug Name
RG3638   DMTQJE0
Synonyms Onartuzumab

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Gastric adenocarcinoma DISWWLTC 2B72 Phase 3 [1]
Non-small-cell lung cancer DIS5Y6R9 2C25.Y Phase 3 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT02488330) An Extension Study of Onartuzumab in Patients With Solid Tumors on Study Treatment Previously Enrolled in a Company Sponsored Study.